(CG) Centerra Gold - Ratings and Ratios

Centerra Gold Inc. is a Canadian-based mining company specializing in the acquisition, exploration, development, and operation of gold, copper, and molybdenum properties across North America, Turkey, and other international locations. The companys portfolio includes the Mount Milligan gold-copper mine in British Columbia, known for its significant gold and copper reserves, and the Öksüt gold mine in Turkey, which has been a key contributor to the companys production growth. Additionally, Centerra owns the Kemess project in British Columbia, a prospective gold-copper development project, and the Goldfield District project in Nevada, USA, which offers exploration potential for gold deposits. The company also operates a Molybdenum Business Unit, including the Langeloth metallurgical processing facility in Pennsylvania, and holds interests in the Thompson Creek Mine in Idaho and the Endako Mine in British Columbia, where it owns a 75% stake. Centerra Gold Inc. was incorporated in 2002 and is headquartered in Toronto, Canada.

From a technical perspective, Centerra Gold Inc. (TO:CG) shows a mixed outlook. The stock is currently trading at $9.14, slightly above its SMA 20 of $9.03 but below its SMA 50 of $8.78. The SMA 200 stands at $8.71, indicating a potential long-term support level. The ATR of 0.37 suggests moderate volatility. Over the next three months, if the stock breaks above the SMA 50, it could test resistance levels near $9.50. Conversely, a breakdown below the SMA 200 could signal a bearish trend, targeting $8.00. The average volume of 602,650 shares over the past 20 days suggests moderate liquidity, which could impact price movements.

Fundamentally, Centerra Gold Inc. has a market capitalization of $2.002 billion CAD, with a trailing P/E of 19.49 and a forward P/E of 10.75, indicating expectations of future earnings growth. The P/B ratio of 0.87 suggests the stock is trading below its book value, potentially signaling undervaluation. The P/S ratio of 1.65 reflects moderate revenue valuation. The return on equity (RoE) of 4.85% is relatively low, indicating limited profitability compared to equity. Over the next three months, investors will likely focus on the companys ability to improve profitability and meet production targets, which could influence its valuation multiples.